Name | Poziotinib | CAS# | 1092364-38-9 | |
---|---|---|---|---|
Price | ¥Inquiry/1g | Purity | 98.9% | |
Stocking Period |
1 Day | Stock | In Stock |
Detail
Product Information
Poziotinib, is an orally bioavailable, quinazoline-based pan epidermal growth factor receptor (EGFR or HER) inhibitor with potential antineoplastic activity. |
Get all suppliers by the below link:
2024-07-15 |
Poziotinib
Price: Inquiry |
2020-01-06 |
Poziotinib
Price: $450.0 |
2021-07-26 |
Poziotinib (HM781-36B)
Price: $Inquiry |
2022-05-12 |
Poziotinib
Price: $Inquiry |
2023-09-14 |
Poziotinib
Price: ¥Inquiry |
2018-09-19 |
Poziotinib
Price: ¥Inquiry |
2021-05-10 |
Poziotinib
Price: ¥Inquiry |
2019-03-19 |
HM781-36B
Price: ¥Inquiry |
2017-11-14 |
Poziotinib
Price: ¥Inquiry |
Get all price from the following link:
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved